Plain-English translation of NCT07706777 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 2 โ Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This clinical trial is testing a new medication called HRS-2129 to see if it can safely and effectively treat acute gout attacks โ the sudden, severe joint pain and swelling that gout causes. The study will compare different doses of this medication to a placebo (an inactive pill) to figure out which dose works best and what side effects, if any, occur.
Current treatments for acute gout don't work well enough for everyone, and doctors need better options to help patients manage these painful attacks. This medication is being tested to see if it offers a safe and more effective way to relieve gout pain.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will be randomly assigned to take either the new medication at one of two doses or a placebo pill. You'll take your assigned treatment during your acute gout attack and attend study visits where the researchers will check your pain level, safety, and how well the medication is working. The study involves about 90 people total, and you'll be monitored to ensure the treatment is safe and effective for you.
AI-generated summary from trial data ยท Oct 12, 2026 ยท Not medical advice
China
Phase
Testing effectiveness
Sponsor
Shandong Suncadia Medicine Co., Ltd.
Enrollment target
~90 participants
Started
August 2026
Primary completion
October 2026
This trial's estimated completion date has passed โ the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in September 2026.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
Lei Tang
Shandong Suncadia Medicine Co., Ltd.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.